Skip to content

Clinical trials

Phase 2 Sjogren's Syndrome trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sjogren's Syndrome Phase: Phase 2 Country / region: Poland Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20171
20191
20213
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Artiva Biotherapeutics, Inc.1
Bristol-Myers Squibb1
Gilead Sciences1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Lakefront Biotherapeutics NV1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sjogren's Syndrome9
Autoimmune Diseases2
Arthritis, Rheumatoid1
Dry Eye Syndromes1
Mixed Connective Tissue Disease1
Myositis1
Rheumatic Diseases1
Scleroderma, Diffuse1
Scleroderma, Systemic1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.